Potential Target Receptors for the Pharmacotherapy of Burning Mouth Syndrome
<b>Objective:</b>Burning mouth syndrome (BMS) is a chronic, intractable orofacial pain condition characterized by a burning sensation in the oral mucosa without discernible lesions. The syndrome predominantly affects menopausal and postmenopausal women and is considered a form of nocipla...
Saved in:
| Main Author: | Takahiko Nagamine |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/6/894 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Brain Networks in Burning Mouth Syndrome: A Narrative Review
by: Takahiko Nagamine
Published: (2025-07-01) -
Burning mouth syndrome
by: W.F.P. van Heerden, et al.
Published: (2011-01-01) -
Commentary: The immediate pain relief of low-level laser therapy for burning mouth syndrome: a retrospective study of 94 cases
by: Takayuki Suga, et al.
Published: (2025-02-01) -
Low-dose aripiprazole for refractory burning mouth syndrome
by: Umezaki Y, et al.
Published: (2016-05-01) -
Clinical features of epileptic syndrome and alteration of NMDAand of AMPA-receptors of glutamate in the pathogenesis of the disease in the patients with supratentorial meningiomas of the brain
by: V. N. Ochkolyas, et al.
Published: (2018-12-01)